Your Launch Plan Is Ready. Your Launch Team Isn’t.
Most biotech leaders understand that launch preparation, building the plan, begins well before expected approval.…
Season of Transitions
Three notable transitions worthy of reflection at this point in time.
The Power of Key Business Questions
In our biopharma world, we frequently hear the term “Key Business Questions (KBQs).” And while it’s often thrown around…
Governance: The Glue to a Successful Launch
At the core of every successful launch lies a meticulously crafted plan, a robust governance structure, and expert…
Juggling Geographic Commercialization Priorities
Commercializing a pharmaceutical asset in one country is hard enough. Doing it on a global scale, with multiple country…
Three Big Mistakes
Over the past 20 years, The NemetzGroup has been involved in the launch of more than 50 different drugs and has had…
How to Write the Biopharma S-1 Business Section
Over the past several years, The NemetzGroup has worked with numerous clients to develop key aspects of their S-1…
There Is No Such Thing as a Free Launch!
We are fortunate to work with clients of all sizes, whose products are at various stages of their life cycle. But the…